Clinical Trial Update: Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 study evaluating fampridine-ER tablets in patients with multiple sclerosis, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Fampridine-ER (fampridine)

Snippet

Sponsor: Acorda Therapeutics | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2013-08-13